» Articles » PMID: 30337455

Programmed DNA Destruction by Miniature CRISPR-Cas14 Enzymes

Overview
Journal Science
Specialty Science
Date 2018 Oct 20
PMID 30337455
Citations 398
Authors
Affiliations
Soon will be listed here.
Abstract

CRISPR-Cas systems provide microbes with adaptive immunity to infectious nucleic acids and are widely employed as genome editing tools. These tools use RNA-guided Cas proteins whose large size (950 to 1400 amino acids) has been considered essential to their specific DNA- or RNA-targeting activities. Here we present a set of CRISPR-Cas systems from uncultivated archaea that contain Cas14, a family of exceptionally compact RNA-guided nucleases (400 to 700 amino acids). Despite their small size, Cas14 proteins are capable of targeted single-stranded DNA (ssDNA) cleavage without restrictive sequence requirements. Moreover, target recognition by Cas14 triggers nonspecific cutting of ssDNA molecules, an activity that enables high-fidelity single-nucleotide polymorphism genotyping (Cas14-DETECTR). Metagenomic data show that multiple CRISPR-Cas14 systems evolved independently and suggest a potential evolutionary origin of single-effector CRISPR-based adaptive immunity.

Citing Articles

Nanotechnology-leveraged CRISPR/Cas systems: icebreaking in trace cancer-related nucleic acids biosensing.

Peng W, Shi M, Hu B, Jia J, Li X, Wang N Mol Cancer. 2025; 24(1):78.

PMID: 40087758 DOI: 10.1186/s12943-024-02222-5.


Efforts to Downsize Base Editors for Clinical Applications.

Song B Int J Mol Sci. 2025; 26(5).

PMID: 40076976 PMC: 11900391. DOI: 10.3390/ijms26052357.


A review of gut failure as a cause and consequence of critical illness.

Soranno D, Coopersmith C, Brinkworth J, Factora F, Muntean J, Mythen M Crit Care. 2025; 29(1):91.

PMID: 40011975 PMC: 11866815. DOI: 10.1186/s13054-025-05309-7.


From Origin to the Present: Establishment, Mechanism, Evolutions and Biomedical Applications of the CRISPR/Cas-Based Macromolecular System in Brief.

Yuan Z Molecules. 2025; 30(4).

PMID: 40005257 PMC: 11858448. DOI: 10.3390/molecules30040947.


Exploiting the Specificity of CRISPR/Cas System for Nucleic Acids Amplification-Free Disease Diagnostics in the Point-of-Care.

Yee B, Ali N, Mohd-Naim N, Ahmed M Chem Bio Eng. 2025; 1(4):330-339.

PMID: 39974464 PMC: 11835143. DOI: 10.1021/cbe.3c00112.


References
1.
Li S, Cheng Q, Liu J, Nie X, Zhao G, Wang J . CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA. Cell Res. 2018; 28(4):491-493. PMC: 5939048. DOI: 10.1038/s41422-018-0022-x. View

2.
Letunic I, Bork P . Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res. 2016; 44(W1):W242-5. PMC: 4987883. DOI: 10.1093/nar/gkw290. View

3.
Abudayyeh O, Gootenberg J, Konermann S, Joung J, Slaymaker I, Cox D . C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 2016; 353(6299):aaf5573. PMC: 5127784. DOI: 10.1126/science.aaf5573. View

4.
Biswas A, Staals R, Morales S, Fineran P, Brown C . CRISPRDetect: A flexible algorithm to define CRISPR arrays. BMC Genomics. 2016; 17:356. PMC: 4869251. DOI: 10.1186/s12864-016-2627-0. View

5.
Liu L, Li X, Ma J, Li Z, You L, Wang J . The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a. Cell. 2017; 170(4):714-726.e10. DOI: 10.1016/j.cell.2017.06.050. View